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This thesis contains two manuscripts that have been prepared for publication. 
The problem statement precedes the first manuscript. The first manuscript reviews the 
immune properties of swine mammary secretions. The second manuscript describes 
experimental and field investigations regarding shedding of porcine reproductive and 
respiratory syndrome (PRRS) virus in swine mammary secretions. The final chapter 
summarizes and discusses the conclusions drawn from the review and research. A 
reference list is included at the end of each manuscript. 
Problem statement 
Porcine reproductive and respiratory syndrome can negatively impact the health of a 
swine herd and impose devastating financial consequences on the producer. 
Management practices that often successfully control other diseases , such as early 
weaning and all-in-all-out protocols, have been less successful in controlling PRRS virus 
infections. As a result, there has been considerable research effort expended to 
understand the mechanisms by which PRRS virus is maintained in infected herds. The 
objective of the research presented here was to explore the role of the lactating sow as a 
potential source of virus via shedding in mammary secretions. Mammary secretions are 
generally perceived as important for providing immunity (immunoglobulins and 
leukocytes) and nutrition to the neonate. We explored the possibility that they also play 
a role in the transmission of PRRS virus. 
2 
IMMUNE COMPONENTS IN 
PORCINE MAMMARY SECRETIONS 
A paper prepared for submission to Viral Immunology 
Elizabeth Allen Wagstrom, DVM, Kyoung-Jin Yoon, DVM, PhD, 
Jeffrey J. Zimmerman, DVM, PhD 
ABSTRACT 
Immune components present in mammary secretions are reviewed. In swine, the 
histological structure of the placenta prevents in utero transfer of immunoglobulins and 
mammary secretions are the sole source of maternal antibody for the neonate. In 
addition to immunoglobulins, porcine mammary secretions contain significant numbers 
of maternal cells of various types that may contribute to neonatal immunity, including 
phagocytes (neutrophils and macrophages), lymphocytes (B and T cells), and epithelial 
cells. Immunomodulating and/or antimicrobial substances, including lactoferrin, 
lysozyme, lactoperoxidase, and cytokines, are also present in mammary secretions and 
may contribute to the protection of the neonate. While the role of immunoglobulins in 
mammary secretions is well understood, the contribution of cellular components and 
non-specific immune factors to neonatal immunity remains to be defined. 
INTRODUCTION 
The immune functions of mammary secretions vary between species, in part due 
to histological differences in placental structure that affect transplacental transfer of 
immunoglobulins between the mother and fetus. In swine and other species in which 
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transplacental transfer of immunoglobulins does not occur, mammary secretions are the 
sole source of maternal antibody for the newborn. In addition, porcine mammary 
secretions contain leukocytes, which are absorbed by the neonate and produce a 
measurable immune activity, and numerous soluble factors with antimicrobial and/or 
immunomodulating activity. This paper will review how immunoglobulins, cells of the 
immune system, and non-specific antimicrobial or immunomodulating factors contribute 
to immunity in the neonatal pig. For the most part, the body of knowledge in this area is 
derived from studies in domestic swine, but the general principles may also be applied to 
feral swine and miniature pigs. 
MAMMARY GLAND FUNCTIONAL ANATOMY 
Domestic swine typically have 12 to 14 mammary glands composed of one to 2 
pairs of thoracic glands, 4 pairs of abdominal glands, and one pair of inguinal glands 
(21 , 22, 42). Each gland is a separate and distinct functional unit with one teat, 2 distinct 
teat canals , 2 teat cisterns, and 2 external openings (21, 42). Within each individual 
mammary gland there are usually 2 entire gland systems, a cranial and caudal gland (21, 
42). At the histological level, epithelial-lined alveoli connect via a common duct to form 
lobules that are joined together by connective tissue to form lobes (21). Myoepithelial 
cells lie between the basement membrane and the epithelial cells of the alveoli and, 
when stimulated by oxytocin, contract to cause milk ejection (21). Finally, the 
mammary glands are supplied by a network of veins, arteries, and lymphatics that lie on 
each side of the ventral midline and extend longitudinally from the axillary to inguinal 
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regions (21, 42). A venous anastomosis exists between the right and left mammary 
gland of each pair (42) . 
Normal mammary development requires the presence of fetuses (38). Nearly all 
of the mammary development in pregnancy occurs during the latter half of the sow' s 115 
day gestation period (26). During this time, histological changes occur as lobuloalveolar 
tissue proliferates and replaces adipose and stromal tissues (26, 37). The formation of 
lobuloalveolar cells is correlated with increased estrogen and progesterone 
concentrations in maternal circulation, coupled with low levels of prolactin (42). 
Growth of the gland is histologically complete by day 90 (42). After day 105 of 
gestation, metabolic activity of the mammary gland is stimulated by decreasing 
progesterone and increasing estrogen levels (42). The hormonal regulation of 
mammogenesis is not clearly understood, but it appears that an increase in estrogen may 
up-regulate prolactin receptors in the mammary gland that, in turn, cause secretory cell 
proliferation and differentiation, and increased mammary wet weight ( 42). In addition, 
relaxin, which is present in increased levels at the end of gestation, has been shown to 
increase growth of the mammary parenchyma (34 ). The signal for milk production by 
the gland is a prolactin spike and an increase in serum corticoids that occurs prior to 
farrowing, in combination with the abrupt decline of serum progesterone that occurs at 
farrowing and the physical removal of colostrum from the gland (30, 42). 
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MAMMARY GLAND IMMUNE SYSTEM 
The immune system of the mammary gland serves two key functions: protection 
of the glands from local infection (15, 54) and provision of immune components to the 
neonate via the mammary secretions (5,15, 52, 54, 64, 69, 93, 97). 
All the cell types required to mount a local immune response are normally 
present in the mammary gland, but the location and distribution of cell types in the 
population of immune cells is affected by reproductive stage (15, 54, 93). Immune cells 
within the mammary gland are primarily located in the interalveolar tissues, but 
lymphocytes are also present in the epithelium and, during lactation, within the alveolar 
lumen (15, 54, 83). The total number of lymphocytes in mammary tissue increases from 
day 80 to 105 of gestation, then decreases during the colostral phase (15, 83). Salmon 
(1987) could not determine whether the decrease represented the movement of a portion 
of these cells into the colostrum or the dilution of the cells by the overall increased wet 
weight of the mammary gland. CD8+ lymphocytes predominate over CD4+ cells in the 
mammary gland, except in late gestation and during lactation when the populations are 
approximately equal (15, 54). It is worth noting that these studies did not identify 
double positive (CD4+CD8+) cells, and for that reason, the estimates may be slightly 
inaccurate. The increased proportion of CD4+ cells in the mammary tissue during 
lactation may indicate local immune activation as CD4+ cells function as helper cells in 
the immune response. 
The number of B cells in mammary tissue is roughly equal to the number of 
IgA+ cells, indicating that most B cells in the mammary gland produce IgA (54). 
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Peripheral B cells, as well as B cells from the gut, migrate into the mammary glands 
(83). These cells protect the mammary gland and also produce maternal antibody for 
transfer to the neonate. The IgA+ cell population is significantly higher at mid-lactation 
than after parturition or after weaning (54). This is consistent with the fact that locally 
produced IgA is the main immunoglobulin in milk, but not in colostrum where IgG is the 
predominant subtype (14, 40, 49, 54, 93). Thus, an increase in IgA-producing cells 
would not be expected until some time after parturition. 
The porcine mammary gland immune system is considered part of the "common 
mucosa! immune system" which consists of intestinal, respiratory, reproductive, and 
mammary lymphoid tissues and the lymphocytes which circulate through them (29, 58, 
76). This is in contrast with ruminants, whose mammary immune system is not as 
closely linked to the common mucosa} immune system (29, 90). There is also an 
immunological link between individual mammary glands. Local production of antibody 
can be stimulated by antigen infusion directly into the mammary gland. Infusion of 
antigen results not only in production of local antibody in the infused gland, but also 
development of a local response in the non-infused glands (2). 
Because of the importance of controlling enteric infections in neonates, much of 
the research on the common mucosa! immune system has explored the link between the 
gut and the mammary gland. This immunological link is mediated by lymphocytes 
moving from the gut and homing to mammary tissues (93). IgA pre-plasma cells, T, and 
B lymphocyte subsets traverse the entero-mammary axis (83). Experimentally, Harp and 
Moon (1988) found that radioactive chromium (51Cr) labeled mesenteric lymphocytes 
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infused intravenously into the original donors could be recovered from the mammary 
gland. 
lgA-secreting plasma cells that colonize the mammary tissue produce antibodies 
that are largely directed against enteric antigens (99), leading to the belief that these cells 
originate in the gut and migrate to the mammary gland. This functional link was 
demonstrated when Bohl et al. (1972) reported the appearance of IgA against 
transmissible gastroenteritis (TGE) virus in sow milk following infection of the 
gastrointestinal tract with the virus and, again by Bourne (1977), with live orally 
administered E. coli resulting in high anti-£. coli IgA levels in the milk. Additionally, 
Kortbeek-Jacobs et al. (1984) demonstrated the preferential localization of sensitized 
IgA producing lymphocytes in the mammary gland of lactating sows following oral 
administration of antigen during gestation. 
An immunological link has also been demonstrated between the mammary gland 
and other mucosa! surfaces. Sows infected late in gestation with pseudorabies 
(Aujeszky' s disease) virus or TGE virus via the upper respiratory tract locally produced 
antibody in the mammary gland (80). In addition, 30% of sows exposed to porcine 
respiratory corona virus (PRCV) via the respiratory route produced anti-PRCV IgA in 
milk, with the percentage increasing to 84% upon re-exposure (81). 
Not only do gut lymphocytes home to the mammary gland but mammary 
lymphocytes also home to other mucosa! lymph nodes. Harp and Moon (1988) 
demonstrated this by injecting 51Cr-labeled mammary lymphocytes into donors and 
identifying these cells within other mucosal lymph nodes. Mammary lymphocytes from 
\ 
8 
lactating sows showed an increased migratory capacity than those from non-lactating 
swine (29). 
IMMUNOGLOBULINS IN MILK AND COLOSTRUM 
Histologically, the porcine placenta consists of six tissue layers and is classified 
as diffuse epitheliochorial (39, 69). Unlike humans, where transfer of IgG to the fetus 
occurs via Fe-dependent transport by receptors located in the placenta (14), the porcine 
placenta does not allow transport of immunoglobulins from the dam to the fetus (5, 14, 
39, 52, 64, 69, 93). Therefore, the neonatal piglet is agammaglobulinemic at birth. In 
swine, maternal antibodies are transported into colostrum via Fe-dependent receptors on 
mammary acinar epithelial cells and neonates acquire maternal antibody through 
consumption of colostrum and absorption of immune components across the 
gastrointestinal tract (14, 28). 
The immunoglobulin composition of sow colostrum differs from sow milk. IgG 
is the principal immunoglobulin in colostrum, while IgA predominates in milk (5, 6, 14, 
93, 98, 104). This difference in immunoglobulin content is explained by the distinctly 
different functions of colostrum and milk. Colostrum is a source of circulating antibody 
for the neonate, while milk provides local antibody protection of the intestinal mucosa. 
Estimates of the ratio of IgA to IgG range from 0.16 to 0.22 in colostrum and 2.1 to 6.96 
in milk (14, 93). 
The difference in the antibody composition of milk versus colostrum is 
hormonally regulated. IgG1 is selectively transported from serum into mammary 
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secretions under the control of the hormones of late pregnancy (69, 93). Mammary 
epithelial cells, influenced by the hormonal interactions of estrogen, progesterone, and 
prolactin during late pregnancy, bind the heavy chain of IgG1 resulting in its selective 
transport over other classes of immunoglobulins (69, 99). Yabiki et al (1974) and 
Franek et al (1975) found that the concentration of each class of immunoglobulin was 
several times higher in colostral whey than in serum during the days proximate to 
parturition, after which time the concentration dropped rapidly. For this reason, levels of 
immunoglobulin in colostrum may be up to 3 times those found in the sow' s serum and 
serum immunoglobulin levels in neonates may be higher than those found in the dam's 
serum (64, 69, 91). 
As the hormones change postpartum, decreased serum progesterone and 
increased serum corticoids serve as a lactogenic trigger with prolactin to cause an 
increase in the secretion of milk and suppression of colostrum production (17, 30, 42). 
Simultaneously, the origin of the antibodies in mammary secretions also changes. In 
colostrum, 100% of IgG and 40% of IgA are derived from serum, while in milk only 
30% of IgG and 10% of IgA is from serum (93). As an indication of increased local 
production and transport of secretory IgA, the proportion of mammary epithelial cells 
expressing secretory component (SC) rises from 20% at parturition to nearly 100% at the 
time of established lactation (49). Secretory component is a portion of a poly-lg receptor 
( 47). This receptor complexes with the J chain of dimeric IgA for transport of IgA to the 
luminal membrane where the receptor is enzymatically cleaved to become SC (47). SC 
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protects the hinge region of secretory IgA from protease cleavage, thus extending its 
survival time in mucosal environments (47). 
The ability of the sow to utilize both serum immunoglobulin and locally 
produced immunoglobulin in mammary secretions contrasts with that of other species 
(99). Ruminants have the ability to transport immunoglobulins from serum to 
colostrum, but have little local IgA production, while rodents and primates locally 
synthesize IgA but have limited ability to transport immunoglobulins from serum to 
mammary secretions (99). Sows' mammary glands are able to produce up to 30 g of IgA 
daily, i.e., up to 30 times the amount produced on a daily basis by humans (14). The 
quantity of immunoglobulin produced by sows is affected by parity and, when 
immunoglobulin concentration is normalized relative to albumin concentration, higher 
parity animals tended to have higher levels of all immunoglobulins in their mammary 
secretions (41). 
Under normal circumstances, immunoglobulins are absorbed through the 
neonate's intestinal epithelium for only a few hours after birth. During the first 24 to 36 
hours post farrowing, the neonatal intestinal epithelial cells are highly vacuolated, 
immature, and capable of absorption of macromolecules, such as immunoglobulins (59, 
91, 100). Absorption of immunoglobulins occurs by endocytosis and subsequent trans-
cellular movement of the macromolecules across the intestinal epithelium (10). All 
classes of antibodies are transported across the intestinal villous epithelium, while the 
intestinal crypt epithelium adsorbs only IgM and IgA classes of immunoglobulin (12). 
This adsorption appears to be mediated by the localization of SC on the lumenal surface 
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of the crypt epithelial cells (12). The efficiency of absorption decreases with a half-life 
of approximately 3 hours, but gut closure is also related to the amount of colostrum 
ingested (5). Gut closure is specifically initiated by the consumption of protein and 
glucose and, for that reason, piglets given only water were still able to absorb colostral 
IgG at 106 hours post farrowing (5, 91, 100). Absorbed colostral immunoglobulins first 
enter the intestinal lymphatic system, then the neonatal blood circulation (99). Absorbed 
IgA is re-secreted onto mucosa! surf aces of the neonate, while IgG stays in the 
circulation (93). Antibodies in milk (mainly IgA) are not absorbed by the intestinal 
epithelium and provide local passive immunity in the gastrointestinal tract. 
There are several mechanisms that serve to protect immunoglobulins in the 
neonates' digestive system. Colostrum is a good buffering compound and protects 
immunoglobulins from denaturation by extremes of pH (99), but the denaturing effects 
of gastric proteases on immunoglobulins must also be minimized if the young pig is to 
receive the benefit of the available immunoglobulins. Colostral IgG1 is more impervious 
to proteolysis by chymotrypsin than other classes of immunoglobulin (99). Further, 
colostral antibodies are protected by 'sow colostrum trypsin inhibitor' (SCTI), a trypsin 
inhibitor specific to colostrum and unrelated to trypsin inhibitors in serum. SCTI, by 
inhibiting trypsin-mediated proteolysis, increases the probability antibodies will be 
absorbed as intact macromolecules (64, 94, 99). There is a positive correlation between 
the level of SCTI a piglet ingests and the amount of IgG and IgA absorbed (94, 95). 
Although the immunoglobulins in milk are not absorbed, they are similarly protected 
from degradation. As an example, lgA in milk is the secretory form of IgA which, due 
12 
to the SC, is more resistant to digestive enzymes, has a higher molecular weight, and is 
more readily distributed in the epithelial mucous than the monomeric form of IgA found 
in serum (104). 
CELLULAR COMPONENTS OF MAMMARY SECRETIONS 
Mammary secretions of all species contain a significant cellular component. In 
swine, secretions contain lymphocytes (T and B cells), phagocytes (neutrophils and 
macrophages), and epithelial cells. As shown in Table 1, estimates of the numbers and 
types of specific cells in porcine mammary secretions vary widely among researchers 
and between individual animals (23, 33, 53, 55, 86, 102). Cell types and quantities are 
affected by stage of lactation and other individual conditions, but the piglet ingests an 
average of 500 to 700 million maternal cells daily (52). 
T lymphocytes. Ten to 25% of cells found in swine colostrum are lymphocytes (23, 
33, 52, 53, 55). Of these, 70 to 90% are T cells (50). In contrast, less than 1 % of the 
cells in milk are T lymphocytes (23, 33, 50, 51, 53, 54, 86, 87). The porcine T cell 
population has some unique features. Pigs have a large population of gamma delta (y8) 
T cells in peripheral blood that have neither CD4 nor CD8 molecules associated with 
them (75). These cells are capable of recognizing intact antigen molecules, although 
their role in disease resistance in not clearly understood (75). In addition, approximately 
15% of porcine peripheral blood T cells express both the CD4 and CD8 antigens on their 
surface (75). Published information about these T cell subsets in the mammary 
secretions of sows is not available, however in human milk there are twice as many 
lymphocytes expressing the y8 receptor as in human blood (52). Le Jan (1994) 
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estimated the ratio of CD4+ to CDS+ cells in colostrum to be (0.57), a significantly 
lower proportion than that of blood (0.80), however he did not identify CD4+/CD8+ 
cells. 
T lymphocytes in mammary secretions are a distinct population of cells that 
show phenotypical differences from those found in peripheral blood (52). They are able 
to express in vitro functional capabilities, e.g., T lymphocytes from sow colostrum 
demonstrate a proliferative response to ovalbumin (23). Memory T cell phenotypes 
predominate among this subset, as indicated by the fact that, relative to T cells in serum, 
a higher proportion of T cells in colostrum express the markers of activation and show 
an increased ability to form thermostable E-rosettes (52, 74). The T cells in sow 
colostrum do not express IL2 receptors, but upon mitogenic stimulation they will 
proliferate and express IL2 receptors (50). 
B lymphocytes. B lymphocytes are less numerous than T lymphocytes in mammary 
secretions (52) and make up only about 30% of the lymphocyte population in the 
mammary secretions of sows (87). It has been demonstrated that B lymphocytes in 
human colostrum are functional (52). In both humans and swine, B lymphocytes 
populations in milk differ from those in blood in the sense that B lymphocytes found in 
milk have a smaller proportion of cells with complement (C ' ) receptors compared to 
those in blood (11, 87). Most B lymphocytes are assumed to have C' receptors, thus it is 
surprising that only about 2% of the lymphocytes in swine mammary secretions 
demonstrate C' receptors (87). There are two possible explanations for this. Possibly, B 
cells in milk may be plasmablasts and/or plasma cells, which are known to lack receptors 
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for complement (11). Alternatively, B lymphocytes lacking C' receptors may be 
selectively transported across the mammary alveolar epithelium (11). 
Phagocytic cells. The phagocytic cell population of mammary secretions consists of 
neutrophils and macrophages. Neutrophils are the predominant phagocyte in mammary 
secretions (33 , 55, 86). Schollenberger et al. (1986c) found that a mixed population of 
phagocytes within sow milk phagocytized, but did not kill, Escherichia coli. The 
intracellular killing index of these cells was >1, while the intracellular killing index for 
blood phagocytes was between 0.14 and 0.25. An index >1 indicated the absence of 
intracellular killing and suggested intracellular multiplication of phagocytized bacteria 
(88). 
The functional capacity of neutrophils from mammary secretions is suspect. 
When compared with neutrophils found in peripheral blood, mammary neutrophils 
exhibit decreased phagocytosis, motility, respiratory burst, and polymorphonuclear-
mediated killing (23, 52). They contain IgA on their surface, but do not release it during 
phagocytosis (44). However, Lee et al. (1983) noted that the neutrophils in sow milk 
exhibited a great capacity to engulf lipid, casein micelles, and cellular debris, thus 
perhaps explaining their lower functional activity. 
Macrophages in mammary secretions have demonstrated functional capability in 
vitro. The level of motility of human milk macrophages is enhanced and they 
demonstrate a greater ability to invade collagen cells than their counterparts from 
peripheral blood (67). In contrast, Evans et al. (1982) found the phagocytic activity of 
milk macrophages in sows to be inferior to that of autologous alveolar macrophages. 
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These milk macrophages contain IgA, and liberate it during the process of phagocytosis 
(52). They also express MHC II antigens, and this expression is enhanced by y interfeon 
(52). As with neutrophils, Lee et al. (1983) observed that macrophages in sow 
mammary secretions engulfed many of the constituent products within secretions, and 
suggested that this may contribute to their decreased functional capacities. 
Epithelial cells. The sow is unique in that epithelial cells are a significant proportion 
of cells in mammary secretions. Approximately 20% of the cellular component in sow 
colostrum is small epithelial cells and 60% of the cellular component of swine milk is 
large epithelial cells. Small epithelial cells contain little or no IgA and are weakly 
positive for the presence of membrane bound SC (49, 52). They may be propagated in 
vitro for several passages (49,52) and, if the epithelial cells in sow colostrum are 
cultivated in the presence of lactating sow serum or an aqueous extract of sow 
colostrum, they undergo differentiation and produce a-lactalbumin (52). They may also 
express MHC II antigen, depending on their degree of differentiation (52). It is believed 
that swine colostral epithelial cells can produce cytokines and function as antigen 
presenting cells (52). In contrast, large epithelial cells are full of fatty globules (23, 53, 
55,64, 86). Large epithelial cells do not grow in vitro, and are morphologically similar 
to differentiated alveolar epithelial cells (52). All milk epithelial cells contain SC and Le 
Jan (1995) found that 66% of them contained intracytoplasmic IgA. However, the 
protective function, if any, of this intracytoplasmic IgA has not been determined. 
Colostral cells in the neonate. It is well established that colostral cells are able to 
cross the intestinal epithelium of the neonatal pig (52, 97, 101). Tuboly et al. (1988) 
16 
demonstrated that only colostral lymphocytes from the piglet's mother are allowed to 
cross the epithelium. Cells from unrelated sows and peripheral blood leukocytes from 
the piglet's mother were unable to cross the intestinal epithelium. Migration of maternal 
lymphocytes occurs in the duodenum and jejunum, but preferentially in the duodenum 
(52, 101). By 24 hours post feeding, maternal lymphocytes are present in the liver, lung, 
lymph nodes, spleen and gastrointestinal tissues of the neonate (101). These maternally-
derived cells produce an altered lymphocyte blastogenesis response to mitogens in the 
neonate. Colostrum-deprived piglets fed maternal colostral lymphocytes showed 
increased peripheral blood leukocyte T cell responses to phytohaemagglutinin and 
concanavalin A and a significant stimulation of B cell responses to pokeweed mi to gen 
when compared to mock piglets or piglets fed maternal peripheral blood leukocytes 
(101). 
Some researchers have suggested that maternal colostral lymphocytes contribute 
to the cell-mediated immunity of the young pig. Evidence from research in other species 
provides some support for this position. Skin lesions resembling those found in graft-
versus-host disease have been induced in Fl hybrid suckling offspring of female rats that 
had rejected Fl hybrid skin allografts (1). Prolonged allograft survival on rats nursed by 
allogenic foster mothers also is evidence for the absorption of, and imrnunomodulation 
by, maternal leukocytes (1 , 31). Graft- versus-host syndrome by maternal lymphocytes 
is also implicated in a "runting syndrome" in rats (66). The transfer of cellular immunity 
mediated by antigen-specific T-cells to Trichinella spiralis in rats has been demonstrated 
(48). In humans, the transfer of maternal T cell reactivity to tuberculin protein via 
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nursing has been noted (85). This sensitivity is absent in non-breast fed babies of 
tuberculin positive women (85). In swine, however, peer-reviewed documentation of the 
transfer of cell mediated immunity to a pathogen from dam to neonate is lacking at 
present. 
OTHER IMMUNOLOGIC FACTORS 
Several early studies described non-specific, in vitro bacteriostatic and 
bactericidal activity in porcine milk and colostrum against Eschericia coli (7, 24, 32, 43, 
62, 79). Metabolically active bacteria were shown to be more susceptible to this activity 
than less active bacteria (62), and anti-£. coli activity decreased over the course of 
lactation (24, 62). Much of the anti-£. coli activity of sow milk and colostrum can be 
attributed to the presence of specific anti-£. coli antibodies, but anti-£. coli activity also 
exists in the absence of antibodies (62). More wide-ranging research has shown that 
mammary secretions from swine and other species contain substances with non-specific 
antimicrobial and/or immunomodulating effects, including lactoferrin, transferrin, 
lysozyme, lactoperoxidase, free cytokines, complement, lipids, carbohydrates, non-
immunoglobulin macromolecules and factor binding proteins (8, 16, 19, 52, 57, 63, 70, 
71, 72). Many of these substances have not yet been characterized in swine. 
Among the antimicrobial substances found in swine mammary secretions are two 
proteins, transferrin and lactoferrin (27, 56). Milk transferrin is identical to serum 
transferrin, while lactoferrin, although closely related to transferrin, is present in milk 
and other exocrine secretions (27, 84). These proteins bind iron, thus keeping the 
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physiological levels of available iron too low for the growth of certain bacteria (24, 27, 
71 , 72). The addition of iron to mammary secretions reduces anti-E. coli activity (24, 
62). The iron-neutralizable transferrin and lactoferrin system appears to be very 
significant in the bactericidal activity of milk and colostrum on E. coli (24, 62). In 
addition to its iron binding function, lactoferrin is known to augment the cytotoxic 
function of natural killer and lymphokine-activated killer cells (89). 
Lysozyme is an enzyme with nonspecific antimicrobial activity found in the 
secretions, tissues, and phagocytic cells of mammals (71). The role of lysozyme in 
swine mammary secretions is not clearly understood, but it is thought to contribute to 
overall antibacterial activity. Only a few bacterial species are susceptible to lysozyme 
alone. However, lysozyme can interact with complement and antibody to acquire the 
capacity to kill a greater range of gram negative bacteria (71). In swine, sigA binds 
complement only in the presence of lysozyme, thereby acquiring bactericidal activity 
(32). Elimination of lysozyme activity does not abolish the bactericidal activity of swine 
mammary secretions, but does reduce its level (62). 
Another antimicrobial constituent of porcine milk is the lactoperoxidase-
thiocyanate-hydrogen peroxide system (72). All three components of the system are 
required for its bacteriostatic activity at near neutral pH or its bactericidal activity at low 
pH in milk and other secretions (71). In this tripartite system, the enzyme combines with 
the peroxide to oxidize the thiocyanate to an intermediary oxidation product which 
inhibits bacterial growth (72). Lactoperoxidase is synthesized in the mammary gland 
and thiocyanate accumulates in the milk (72). This system is especially effective against 
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Streptococcus spp., which metabolically produce peroxide, thus contributing to their 
own inhibition (71, 72). Other bacteria are also inhibited when a source of exogenous 
peroxide is available (71 , 72). 
The biologically active forms of immunologically important cytokines have been 
found in the mammary secretions of several species (52). In swine, most of the 
cytokines identified have been growth factors, including epidermal growth factor (EGF), 
insulin-like growth factor (IGF) and transforming growth factor-beta (TGF-~) (9, 18, 36, 
65, 103). It is believed that these growth factors may provide important regulatory 
signals to the neonatal intestine under both normal and pathophysiological conditions 
(65). In addition to growth factors, cytokines identified in human mammary secretions 
include: interleukin (IL)-1, IL-6, IL-8, interferon-gamma (IFN-y), and tumor necrosis 
factor-alpha (TNF-a) (3, 20, 60, 61, 68, 73 , 77, 78, 82). Human colostral samples have 
an antiviral activity greater than that of plasma, indicating that the interferon in 
colostrum is biologically active (3). Human colostral, milk, and mammary epithelial 
cells have demonstrated in vitro capacity to produce cytokines (57, 60, 68). In cattle, 
TNF levels are lactation stage-dependent and the antiviral activity of mammary 
secretions attributed to TNF increases as parturition approaches (73, 92). Limited data 
are available on the levels and functions of cytokines in human and bovine mammary 
secretions and even less on porcine milk or colostrum. However, the current information 
suggests that cytokines may play a role in the development and maturation of the 
newbom's immune system (3). Cytokines are known to induce numerous physiologic 
responses including the development of cellular and humoral immune responses, 
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induction of the inflammatory response, regulation of hematopoesis, control of cellular 
proliferation and differentiation, and the induction of wound healing (47). Virus-
induced human colostral cell cytokine stimulation of both adult and neonatal natural 
killer cell cytotoxicity has been demonstrated ( 45). While most of the research on 
mammary secretion cytokines has been conducted on human or bovine secretions, it is 
reasonable to expect that swine mammary secretions contain biologically active 
cytokines that could contribute to the immune protection of the neonate. 
Milk lipids also serve a protective function. Following storage in vitro, or 
digestion in vivo, lipids demonstrate antiviral, antibacterial, and antiprotozoal activity 
(35). This activity is due to free fatty acids and monoglycerides that are released from 
milk triglycerides after they are exposed to lipases (35). Enveloped viruses are more 
susceptible to inactivation by free fatty acids than are bacteria, and human milk and milk 
stomach contents have been shown to inactivate HIV and other enveloped viruses (35). 
In addition to those given above, there are several other antimicrobial and 
immunomodulating substances described in bovine and/or human mammary secretions, 
including complement, carbohydrates, non-immunoglobulin macromolecules, and factor 
binding proteins (57). Some of these factors neutralize viruses or lyse bacteria directly 
or in conjunction with other immune components (complement) while others bind 
nutrients required for bacterial growth (factor binding proteins) (57). Others have 
exclusively anti-viral effects (non-immunoglobulin macromolecules, ribonuclease, 
hemagglutinin inhibitors), including an unidentified factor in human milk that inhibits 
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the binding of HIV to its CD4 receptor (57, 63). Similar substances have not yet been 
characterized in swine. 
SUMMARY 
The primary immunological function of swine mammary secretions has 
traditionally been considered to be the transfer of maternal immunoglobulins to the 
neonate. While the contribution of maternal antibodies to neonatal immunity is 
important, the role of cellular and non-specific immunological components in milk and 
colostrum is also gaining recognition. The presence of cells in mammary secretions has 
been recognized for many years, but our understanding of these cells and their functions 
is incomplete. Functionally, cells in mammary secretions appear to provide local 
protection in the intestine of the neonate and, as circulating peripheral blood leukocytes 
in the piglet, contribute to an increased proliferative response to mitogens. Whether this 
increased proliferative response truly represents the transfer of cell-mediated immunity 
from the dam is one of several issues that remains to be resolved. 
Non-specific immune factors are also present in swine mammary secretions and 
exert measurable anti-microbial effects, e.g., anti-£. coli activity. Included among these 
factors are lactoferrin, lysozyme, lactoperoxidase, free cytokines, complement, lipids, 
carbohydrates, non-immunoglobulin macromolecules and factor binding proteins. For 
the most part, our understanding of the contribution of these non-specific factors to the 
overall immune function of mammary secretions in swine is minimal. Thus, while the 
role of immunoglobulins in mammary secretions on the immune status of the neonate is 
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well understood, the contributions of the cellular portion and non-specific immune 
factors present in these secretions needs to be defined. In the long term, such studies 
off er the potential benefit of providing new approaches to immunological intervention 
strategies for disease prevention in the neonatal pig and other species. 
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Table 1. Reported cell counts in colostrum and milk of sows 
Day of PMN M0 Lymphocytes Epithelial Cells Reference 
lactation % % % % Cited 
0 71.7 1.3 26.4 0.4 23 
0 64.0 5.6 26.5 1.4 102 
0 58.0 11.2 14.9 7.8 54 
-65.5 -1.6 -19.8 -1.4 
0 55.5 34.9 9.5 33 
0 62.7 24.5 8.8 2.5 53 
1 - 2 61.2 6.6 10.6 19.6 86 
1 61.2 18.3 6.5 12.0 53 
2 45.4 11.2 6.7 34.7 53 
3 55.4 15.0 22.8 6.1 23 
3 30.3 59.9 9.8 33 
3-7 50.9 8.8 11.4 26.3 86 
4 40.7 15.5 19.2 23.6 102 
4 44.5 8.6 7.9 36.8 53 
7 13.9 1.2 4.8 69.0 55 
-20.9 -3.6 -6.6 -80.2 
7 25.6 67.4 7.0 33 
7 36.5 9.3 14.8 39.1 53 
8 - 14 41.5 12.6 11.1 35.8 86 
10 39.2 14.6 13.7 31.4 23 
14 7.6 1.6 1.9 74.2 55 
-18.4 -3.6 -3.8 -88.9 
14 11.7 76.9 11.3 33 
14 27.2 19.4 6.0 45.7 53 
15 - 43.9 11.2 12.2 32.6 86 
21 
15 51.3 5.5 11.2 31.3 23 
20 32.1 0.0 0.0 67.9 23 
21 13.9 80.5 5.6 33 
21 29.3 13.3 6.1 50.1 53 
22 - 50.4 7.2 12.0 30.3 86 
31 
28 14.2 1.6 2.6 60.1 55 
-33.0 -4.2 -3 .8 -80.1 
28 43.5 51.9 4.6 33 
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AND RESPIRATORY SYNDROME (PRRS) VIRUS 
IN MAMMARY SECRETIONS OF SOWS 
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Elizabeth Allen Wagstrom, DVM, MS, Chih-Cheng Chang, DVM, MS, 
Kyoung-Jin Yoon, DVM, PhD, Jeffrey J. Zimmerman, DVM, PhD 
Abstract 
The objective of these studies was to investigate shedding of porcine 
reproductive and respiratory syndrome (PRRS) virus in the mammary secretions of 
lactating sows. Three studies were conducted. In Experiment 1, PRRS virus-naive 
pregnant females (n = 4) were either inoculated intramuscularly with a modified live 
PRRS vaccine virus (n = 2) or intranasally (IN) exposed to a PRRS field isolate (n = 2) 
late in gestation. Mammary secretions were collected from each sow for 18 days post 
farrowing. Infectious PRRS virus was detected in the mammary secretions of 2 of 2 
sows exposed to vaccine virus and 1 of 2 sows exposed to field virus. In Experiment 2, 
the 2 sows exposed to vaccine virus in Experiment 1 were inoculated with a different 
PRRS modified live vaccine virus on day 102 of gestation. Samples were collected, 
processed and tested as in Experiment 1, but PRRS virus was not detected in the 
mammary secretions of these sows. Experiment 3 was conducted to estimate the 
frequency at which PRRS virus was shed in the mammary secretions of sows in 
commercial swine units. Mammary secretions were collected from 202 sows in 10 (2 
PRRS virus negative, 8 PRRS virus positive) swine herds in Iowa. Samples were 
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processed and assayed as in Experiments 1 and 2, but PRRS virus was not detected in 
any of the samples. 
PRRS virus was demonstrated in the mammary secretions of nai"ve swine 
exposed to virus in late gestation, but not in samples from convalescent sows. Neither 
re-exposure in late gestation or re-vaccination postpartum resulted in detectable levels 
of infectious virus in mammary secretions. Although milk-borne transmission may play 
a role in the transmission of virus to neonates under specific circumstances, it does not 
appear to be a mechanism by which PRRS virus is routinely transmitted from dams to 
neonates in endemically infected herds. 
Keywords: Porcine reproductive and respiratory syndrome, transmission, mammary 
secretions, milk-borne transmission 
1. Introduction 
Porcine reproductive and respiratory syndrome (PRRS) was first reported in the 
United States in 1989 (Keffaber, 1989; Loula, 1991), although serologic evidence 
suggested that the virus was present in Canada by 1979 (Carmen et al., 1995). The 
etiological agent was identified in 1991 when Koch's postulates were fulfilled with a 
previously unknown virus (Terpstra et al., 1991; Wensvoort et al., 1991). Shortly 
thereafter, isolation of PRRS virus was reported in North America (Collins et al., 1992; 
Dea et al., 1992). 
PRRS virus is a small, enveloped, single-stranded RNA virus (Benfield et al., 
1992; Wensvoort, 1993) in the genus Arterivirus of the family Arteriviridae in the order 
Nidovirales (Conzelmann et al., 1993, Meulenberg et al., 1993; Pringle, 1996; 
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Cavanagh, 1997). Other viruses in the genus Arterivirus include lactate dehydrogenase-
elevating virus (LDV) of mice, equine arteritis virus (EA V), and simian hemorrhagic 
fever virus (SHFV) (Plagemann 1992; Plagemann and Moennig, 1992). These viruses 
replicate primarily in host macrophages and are known to establish asymptomatic 
persistent infections in host species (Plagemann and Moennig, 1992). 
Although not highly contagious, PRRS virus is highly infectious, i.e., has a low 
minimum infectious dose (Yoon et al., 1999). Infection may result from any of several 
routes of exposure, including oral, intranasal, intramuscular, intraperitoneal, intravenous, 
intratracheal, and intravaginal (Zimmerman et al., 1998). Infection results in shedding 
of virus in bodily fluids. PRRS virus has been detected in saliva for up to 42 days and in 
urine for up to 14 days post inoculation (Wills et al., 1997a ). Virus has also been 
detected from nasal swabs for 9 to 21 days post inoculation (Christianson et al., 1993; 
Benfield et al. , 1994) and in semen for as long as 92 days following exposure 
(Christopher-Hennings et al., 1995). There are discrepant reports of PRRS virus 
shedding in feces (Christianson et al. , 1993; Yoon et al., 1993; Rossow et al., 1994; 
Wills et al. , 1997a), but virus in fecal slurry is rapidly inactivated (Pirtle and Beran, 
1996). 
In the majority of infected herds, an endemic cycle of PRRS virus transmission is 
established that maintains the infection indefinitely. For example, isolation of PRRS 
virus was reported from nursery pigs in a herd 2.5 years after the initial introduction of 
the virus (Joo and Dee, 1993). The mechanisms by which herds remain endemically 
infected are not well documented, but chronic carriers probably play a major role in 
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maintenance and dissemination of the virus. Transmission from carriers to susceptible 
animals was demonstrated 99 days after exposure to PRRS virus (Zimmerman et al, 
1992) and Wills et al. (1997b) recovered infectious virus for up to 157 days post 
inoculation (Pl). Thus, susceptible animals introduced into a herd through purchase or 
birth probably become infected by exposure to carrier animals (Wills et al., 1997b). 
Transmission may occur between sows and their offspring and, perhaps for that reason, 
early weaning protocols have been largely unsuccessful in eliminating PRRS virus 
(Clark et al, 1994; Fangman et al. , 1996; Senn et al. , 1998). 
Voicu et al. (1994) were the first to suggest that PRRS virus might be shed in 
milk and colostrum, thereby serving as a means of transmission in endemically infected 
herds. In support of this hypothesis was the fact that transmission of LDV, the murine 
arterivirus, is known to occur via mammary secretions (Broen and Cafruny, 1993). 
Broen and Cafruny (1993) demonstrated that acutely infected mice transmitted LDV to 
their offspring with an efficiency of up to 83% and confirmed the presence of virus in 
the mammary secretions of lactating mice. 
The primary objective of this study was to determine if infectious PRRS virus 
was shed in colostrum and/or milk. After demonstrating the presence of infectious virus 
in mammary secretions, we examined the effect of previous exposure to PRRS virus on 
viral shedding in the subsequent lactation. Finally, we collected milk samples from sows 
in commercial herds to estimate the frequency of PRRS virus shedding during lactation 
in the field. 
2. Materials and methods 
2.1 - Swine and housing 
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In Experiment 1, 6 crossbred dams in the last trimester of pregnancy were 
obtained from a herd known to be free of PRRS virus. After arrival, animals were 
confirmed to be seronegative for PRRS virus antibodies using a commercial ELISA 
(IDEXX Laboratories, Westbrook, ME). Sows were housed one per room throughout 
Experiment 1. Two of these sows were retained for Experiment 2. In Experiment 2, the 
2 animals were housed together in one room until 10 days prior to farrowing, at which 
time they were moved into farrowing crates in individual rooms. In Experiment 3, 
mammary secretions were collected from 202 sows in 10 different commercial swine 
units located in southern and central Iowa. Herds ranged in size from 30 to 4000 sows. 
Two of these herds were considered PRRS virus-free on the basis of repeated serological 
and virological monitoring. The 8 infected herds had either experienced a clinical 
outbreak of PRRS and/or had administered a modified live PRRS vaccine to animals in 
the herd within the previous 6 months. None of the infected herds was undergoing 
clinical PRRS at the time of sample collection. On positive farms, 114 of the 181 sows 
had been vaccinated with a modified-live virus (l\1L V) PRRS vaccine during gestation. 
Of the 114 animals that had been vaccinated during gestation, 46 had also been 
vaccinated post-farrowing, i.e., 1 to 3 days prior to collection of the mammary 
secretions. All mammary secretion samples in Experiment 3 were collected from sows 
that were in days 1 to 6 of lactation. 
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For swine bioassays, 3- to 5-week-old pigs were obtained from a PRRS virus-
free herd and housed in individual HEPA-filtered isolation units (Barner Systems, Inc. , 
Tom River, NJ). Pigs were confirmed to be free of PRRS virus infection by ELISA 
prior to inoculation with assay samples. 
2.2 - Virus 
A PRRS virus field isolate (ISU-P) and 2 commercial PRRS vaccines were used in 
the study. Isolate ISU-P was recovered in 1992 from a homogenate prepared from a 
pool of lungs collected from young pigs in a herd in Illinois that was undergoing an 
acute outbreak of respiratory disease. Porcine alveolar macrophages were used for the 
initial isolation. The virus was propagated in MARC-145, a highly permissive clone of 
African Monkey kidney cells (Kim et al. , 1993) and represented six in vitro passages. 
The titer of virus inoculum used in the study was determined using a microtitration 
infectivity assay, as described elsewhere (Yoon et al., 1996). Median tissue culture 
infective dose (TCID5o/ml) was calculated using the Karber method (Schmidt and 
Emmons, 1989). 
Based on the assay described by Wesley et al. (1998), the vaccine virus (Boehringer 
Ingelheim Animal Health, St. Joseph, MO) used in Experiment 1 had a predicted 
restiction fragment length polymorphism (RFLP) cut pattern of 2-5-2 and varied by 73 
of 960 sequenced base pairs in ORFs 5 and 6 from the vaccine used in Experiment 2 
(Schering-Plough Animal Health, Kenilworth, NJ) (Collins et al. , 1998). The vaccine 
virus used in Experiment 2 had a predicted RFLP cut pattern of 1-4-4 (Collins et al., 
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1998). When reacted against a panel of 24 monoclonal antibodies raised against the 15 
kD nucleocapsid protein of PRRS isolate ISU-P, both vaccine viruses fell into the same 
antigenic group (Yang et al., 1999). 
2.3 - Virus inoculation 
Two sows in Experiment 1 were inoculated intranasally (IN) with 2 ml per naris of 
PRRS virus isolate ISU-P at a concentration of 103·5 TCID5o/ml on day 84 (Sow 63) or 
90 (Sow 85) of gestation. An additional 2 sows in Experiment 1 were administered 2 ml 
of a modified live virus (ML V) PRRS vaccine (Boehringer Ingelheim Animal Health, St 
Joeseph, MO) intramuscularly (IM) on day 86 (Sow 82) or 97 (Sow 62) of gestation. In 
Experiment 2, these latter 2 sows were intramuscularly (IM) administered 2 ml of a 
different ML V PRRS vaccine (Schering-Plough Animal Health, Kenilworth, NJ) on day 
102 of gestation. 
2.4 - Sow synchronization, insemination, and induction of farrowing 
The 2 sows retained for Experiment 2 were synchronized using 7 ml per os of 
altrenogest (Hoechst-Roussel Agri-Vet, Sommerville, NJ) daily for 7 days. On the 
morning of day 8, each sow was injected in the vulva with one ml of cloprostenol 
sodium (Bayer Animal Health, Shawnee Mission, KS). In the evening of day 8, each 
sow was injected in the vulva with one ml of cloprostenol sodium and IM with 5 ml of a 
combination of serum gonadotropin and chorionic gonadotropin (lntervet, Millsboro, 
DE). In the evening of day 11, each sow was injected IM with 10 ml of human 
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chorionic gonadotropin (Intervet, Millsbor, DE). Sows were artificially inseminated in 
the evening of days 12 and 13. The semen was collected from a boar in the same PRRS 
virus-free herd that supplied the sows. On day 114 after the first insemination, sows 
were injected with one ml of cloprostenol sodium in the vulva to induce parturition. 
2.5 - Serum samples 
Blood samples were drawn via venapuncture and the serum separated after 30 
min at room temperature by centrifugation at 1000 x g for 10 minutes. Serum samples 
for serological tests were stored at -20° C until the assays were performed. In 
Experiment 1, serum samples were collected from each sow 7 to 14 days prior to 
exposure to virus, on the day of exposure, and 2 weeks later. Another sample was 
collected at farrowing and a final sample collected 18 days after farrowing. In 
Experiment 2, serum samples were collected from each sow monthly during gestation, at 
the time of exposure to virus, the day after farrowing, and on day 20 or 21 post 
farrowing. In Experiment 3, serum samples were collected from each sow at the time of 
mammary secretion collection. 
2.6 - Mammary secretion collection 
Milk ejection was stimulated with IM injection of 40 to 80 USP Posterior 
Pituitary Units of oxytocin (Phoenix Pharmaceutical Co., St. Joeseph, MO). Mammary 
secretions were collected by manual expression of several glands into siliconized glass 
containers. In Experiment 1, 75 to 80 ml were collected daily from each sow for 16 to 
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19 days post farrowing. In Experiment 2, approximately 225 ml were collected daily 
from each sow for 18 days post farrowing. In Experiment 3, approximately 225 ml of 
mammary secretions were collected from each sow. 
2. 7 - Mammary secretion processing 
Milk and colostrum samples were chilled immediately upon collection from sows 
by packing in wet ice. In the laboratory, samples were processed as follows. An 
undiluted 15 ml portion of the sample was separated and centrifuged at 400 x g for 20 
minutes. The whey portion, i.e., the liquid between the upper lipid layer and the bottom 
cell pellet, was drawn off, aliquoted into 4 plastic tubes (Fisher Scientific, Chicago, IL), 
and frozen at -20° C until assayed for antibodies and PRRS virus. The cell fraction of 
each mammary secretion sample was processed for virus detection as follows. Samples 
were diluted 1 :2.5 with Hanks' balanced salts solution (HBSS) (Sigma Chemical Co., St. 
Louis, MO) supplemented with 50 µg/ml gentamicin (Schering-Plough Animal Health, 
Kenilworth, NJ) and 0.25 µg/ml amphotericin B (Sigma Chemical Co., St. Louis, MO) 
then centrifuged at 400 x g for 20 minutes at 4 ° C. The lipid and whey layers were 
discarded and the remaining cell pellet was suspended in HBSS and centrifuged at 400 x 
g for 10 minutes at 4 ° C. This was repeated for a total of 3 washes, after which the cell 
pellet was resuspended. In Experiment 1, the cells were resuspended in 12 ml of HBSS. 
In Experiment 2 and Experiment 3, the cell pellet was resuspended in 12 ml of minimum 
essential medium (MEM) supplemented with lOmM HEPES (Gibco, Grand Island, NY), 
50 µg/ml gentamicin, 0.25 µg/ml amphotericin B, 4% fetal calf serum (FCS) (Sigma 
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Chemical Co., St. Louis, MO), and 2mM L-glutamine (Gibco, Grand Island, NY). The 
cell suspensions were aliquoted into 4 tubes and stored at -20° C until assayed for virus. 
2.8 - Serologic testing 
Serum and whey samples were tested for the presence of antibodies specific for 
PRRS virus with a commercial ELISA kit following the procedures recommended by the 
manufacturer. 
2.9 - Virus isolation 
Virus isolation (VI) was conducted separately on mammary secretion cell 
samples and whey samples. For all samples, VI was attempted on both porcine alveolar 
macrophages (PAMs) and MARC-145 cells using procedures previously described 
(Yoon et al. , 1996). For VI on PAMs, cells were prepared in 48-well plates (Corning 
Glass Works, Corning, NY) using RPMI-1640 (Gibco, Grand Island, NY) medium 
supplemented with 10% FCS, lOmM HEPES, lO0IU/ml penicillin, 100 µg/ml 
streptomycin (Schering-Plough Animal Health, Kenilworth, NJ), 50 µg/ml gentamicin 
and 0.25 µg/ml amphotericin B (RPMI growth medium). After a 48-hour incubation, the 
cells were inoculated with samples (0.2 ml/well). All cell suspensions and whey 
samples were freeze-thawed and then centrifuged at 1500 x g for 15 minutes prior to 
inoculation. Each sample was run in duplicate. Inoculated cells were incubated for 60 
to 90 minutes at 37° C, then replenished with freshly prepared RMPI growth medium. 
Cells inoculated with whey were washed once with serum-free RPMI-1640 prior to the 
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addition of fresh RPMI growth medium. Cells were then incubated at 37° Cina 5% 
CO2 atmosphere for 5 to 7 days and monitored periodically for cytopathic effect (CPE). 
After 5 to 7 days, or upon the appearance of CPE, cells were subjected to freeze-
thawing. The presence of PRRS virus was confirmed by subinoculating cell culture 
supernatant (100 µl) onto 24-hour-old MARC-145 cells prepared in 48-well plates, 
incubating inoculated cells for 48 to 72 hours, and performing imrnunofluorescence 
microscopy using a PRRS virus-specific monoclonal antibody (SDOW-17) (Provided by 
Dr. David Benfield, South Dakota State University, Brookings, SD) labeled with 
fluoroisothiocyanate (FITC). 
Virus isolation was repeated on MARC-145 cells using a procedure identical to 
that described for P AMs, except that cells were prepared in 24-well plates (Corning 
Glass Works, Corning, NY) for initial isolation and MEM was used as medium basis 
instead of RPMI-1640. 
2.10 - Swine Bioassay 
Virus isolation-negative samples were also tested for PRRS virus by swine 
bioassay. In Experiment 1, VI-negative cell suspensions samples from across a single 
sow' s lactation period were pooled and 15 ml of the pooled sample inoculated IM into 
one bioassay pig. Similarly, VI-negative whey samples from across a saw's lactation 
were pooled and 15 ml inoculated IM into a second bioassay pig. To serve as a bioassay 
negative control, cell suspension and whey samples frqm each of the 2 control sows 
were pooled and 15 ml of the combined sample inoculated IM into a bioassay pig. 
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In Experiment 2, 1 ml of VI-negative cell suspension sample from each day of a 
sow' s lactation was pooled and inoculated IM into a single bioassay pig. In addition, 1 
ml of VI-negative whey from days 1 to 9 were pooled and administered IM into one 
bioassay pig, while one ml of whey from days 10 to 18 of lactation were pooled and 
injected into a second pig. One pig was injected with medium only and served as a 
negative control. 
In Experiment 3, one ml of cell suspension and one ml of whey from 10 VI-
negative sow samples were pooled and inoculated into a single pig. One bioassay pig 
received mammary secretions from a known negative farm to serve as a negative 
control. 
In all cases, serum samples were collected from bioassay pigs weekly following 
inoculation and assayed for virus and antibody by VI and ELISA, respectively. Samples 
were considered positive for the presence of infectious PRRS virus if virus was isolated 
from serum and/or ELISA SIP ratios ~ 0.4 antibody were observed in 2 consecutive 
samples. Bioassay pigs were followed for 4 weeks after inoculation. 
3. Results 
In Experiment 1, infectious PRRS virus was detected in mammary secretions 
collected from 3 sows inoculated with either vaccine strain or field virus (Table 1). 
Virus was detected in the mammary secretions from 1 of 2 field virus-inoculated sows 
and 2 of 2 sows inoculated with a ML V PRRS virus vaccine. Virus was detected in both 
cell and whey samples. Virus was isolated from whey (day 5) and from cell fractions 
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(days 8 and 9) collected from sow 85. In addition, a pooled inoculum consisting of VI-
negative whey samples from sow 85 was positive for infectious PRRS virus by swine 
bioassay, indicating that virus was present but undetected by VI on one or more days. In 
vaccine-virus inoculated sows, virus was isolated from cell fractions collected from sow 
62 (days 2 and 4) and detected in VI-negative whey samples from both sows in this 
group by swine bioassay. Virus isolation-negative cell suspensions from both vaccine-
inoculated sows were also negative by swine bioassay. In contrast to Experiment 1, 
PRRS virus was not detected by VI or swine bioassay in any of the 36 mammary 
secretion samples collected in Experiment 2. In Experiment 3, none of the samples 
collected from 202 lactating sows in 10 commercial herds were positive for PRRS by 
either VI or swine bioassay. 
Serum antibody response of sows inoculated with vaccine virus or field virus is 
given in Figure 1. All inoculated sows in Experiment 1 and 2 responded by producing 
ELISA-detectable antibodies. No antibody response was detected in negative control 
sows. The ELISA sample-to-positive (SIP) ratios of sows declined over time, but an 
anamnestic response was observed when animals were re-exposed to vaccine virus in 
Experiment 2. 
PRRS virus-specific antibodies were also detected in undiluted whey from sows 
experimentally exposed to either vaccine virus or field virus (Figure 2). In Experiments 
1 and 2, ELISA SIP values for whey samples collected in early lactation were equal to, 
or greater than, SIP values for serum samples collected from the same sow at the same 
point in time. ELISA SIP values declined rapidly through the lactation period to levels 
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much lower than those found in serum. No PRRSV antibody was detected in whey 
samples from negative control sows. 
In Experiment 3, serum samples from 21 of 21 sows from negative farms were 
below the positive cutoff ( <0.40). In this group, the SIP values on serum samples ranged 
from 0.00 to 0.14, with a mean of 0.02. Among this same group of sows, SIP values on 
whey samples ranged from 0.00 to 0.09, with a mean of 0.02. In PRRS virus-positive 
herds, serum samples from 124 of 181 sows were ELISA positive (~0.40). Among these 
181 animals, SIP ratios ranged from 0.04 to 2.96, with a mean of 0.81. Whey from 38 of 
181 sows from positive farms was considered positive on ELISA. Among these 181 
mammary samples, SIP ratios ranged from 0.02 - 2.48, with a mean SIP ratio of 0.27. 
4. Discussion 
Despite the recognized benefits of mammary secretions to the neonate, there is 
also a risk of disease transmission. There are numerous reports in the literature of viral 
(Table 2), bacterial, and parasitic pathogens shed in the milk of various species of 
animals. Because TGE virus and LDV are members of order Nidovirales, like PRRS 
virus, transmission of TGE virus and LDV via mammary secretions is of particular 
relevance to the current research. Kemeny and Woods (1977) showed shedding of TGE 
virus in the milk of sows inoculated by intravenous (IV), intranasal (IN), and 
intramammary routes. Shedding of TGE virus in mammary secretions was demonstrated 
for 5 days PI in sows inoculated IV, 3 days in sows inoculated IN, and greater than 6 
days in sows inoculated directly into the mammary glands. Transmission of the virus via 
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mammary secretions was demonstrated by infection of 47.5% of orphan piglets fed the 
milk of infected sows. All sows in the study were nai"ve to TGE virus at the time of 
inoculation, but did develop high serum levels of virus-neutralizing antibody by the end 
of the experiment. The effect of previous exposure to virus, the presence of serum 
antibodies, or milk antibody levels on viral shedding in milk was not investigated. 
Broen and Cafruny (1993) demonstrated a nursing pathway for the transmission 
of LDV, an arterivirus closely related to PRRS virus, and reported the presence of LDV 
in mammary secretions. Depending on the genotype, up to 83% of acutely infected 
female mice transmitted LDV to their nursing offspring, while only 1 in 14 mice nursing 
chronically LDV-infected immunocompetent mothers became infected. Milk and 
plasma from acutely infected mothers contained high titers of virus, in contrast to lower 
titers of virus found in the milk and plasma of chronically infected mice. Thus, the 
authors concluded that reduced milk transmission of LDV was correlated to 
development of maternal anti-viral immunity and reduced titers of LDV in plasma and 
milk 
In this study, we found that nai"ve animals exposed to live PRRS virus in late 
gestation shed virus in mammary secretions. Infectious virus was detected in lactation 
samples using both in vitro and swine bioassay techniques. Swine bioassay was utilized 
to support in vitro techniques because of the analytic sensitivity of the assay for 
infectious virus. The use of animal inoculation for the detection of PRRS virus was first 
described by Swenson et al. (1994) as a useful research technique for detection of 
infectious PRRS virus in biological samples that were not amenable to in vitro virus 
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isolation procedures. Yoon et al. (1999) reported the minimum infectious dose for PRRS 
virus in young swine as :Sl O virus particles by either intramuscular or intranasal 
exposure. In this study, the bioassay results demonstrated that virus was present in 
mammary secretions at levels below the threshold of detection by virus isolation but 
above the minimum infectious dose for swine. 
Intermittent isolation of virus from individual sows suggested that virus was 
present at levels near or below the limit of in vitro detection. It is also possible that virus 
was shed sporadically and/or that antibodies against PRRS virus or components toxic to 
cells adversely affected in vitro isolation. Matthews, et al. (1976) described a 
macromolecule in the non-lipid fraction of cow and human milk with anti-viral 
properties. In human milk, immunoglobulins, lipids, ribonuclease, haemagglutinin, and 
leukocytes have been shown to have antiviral effects (May, 1988; Isaacs 1991). 
It was not possible to determine whether virus was free in mammary secretions 
or associated with virus-infected cells. PRRS virus replicates within macrophages , and 
macrophages are numerous in sow mammary secretions (Evans, 1982; Lee, 1983; LeJan, 
1996; Schollengerger, et al., 1986; Hurley, 1988). For that reason, detection of virus in 
the cell fraction of mammary secretion samples would not be unexpected. However, 
virus was also detected in whey samples. Whether virus was actually free in whey or the 
result of incomplete separation of infected cells from whey by centrifugation could not 
be ascertained. 
In Experiment 2, previously inoculated sows did not shed virus in a subsequent 
lactation when administered a different modified live vaccine virus late in gestation. 
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Although the Experiment 2 sample size was small (n = 2), the results suggested that 
prior exposure precluded virus shedding virus in the subsequent lactation. It is possible 
that the virus used in Experiment 2 was not sufficiently heterologous to evade the 
immunity conferred by exposure to the virus used in Experiment 1. Christopher-
Hennings et al. (1997) found that 3 of 5 boars administered a MLV PRRS vaccine shed 
wild-type virus in semen when challenged 50 days post-vaccination with wild-type 
virus, although vaccination did appear to reduce the duration of semen shedding. Boars 
inoculated with a wild type virus and re-challenged 128 days later with the same wild 
type virus did not shed virus in semen (Christopher-Hennings et al., 1995). These 
findings would suggest that previous exposure averts semen shedding in a homologous 
challenge and reduces shedding with a heterologous virus challenge. 
The results of Experiment 3 supported the observations from Experiment 2. 
Among the 181 sows sampled in 8 endemically infected herds, all had either been 
vaccinated or were in herds that had been clinically affected by PRRS. Forty-six 
animals had been re-vaccinated within 72 hours of mammary secretion collection, but no 
virus was detected in their lactation samples. These observations strongly suggested 
that, excluding the possible impact of the presence of nai"ve subpopulations of gilts or 
sows or the entry of a highly heterologous field virus, PRRS virus shedding in colostrum 
and milk is rare in endemically infected herds. 
Shedding of PRRS virus in saliva, urine, nasal secretions, and semen was 
previously recognized. This is the first report of shedding of PRRS virus in mammary 
secretions. Additional research is required to determine the mechanism of such shedding, 
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ie., whether virus is contained in mammary macrophages or free within the whey portion 
of the mammary secretions. Further studies are also required to characterize the effect of 
immunity on shedding of homologous or heterologous virus by convalescent sows. 
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Table 1. Detection of PRRS virus in mammary secretions (Experiment 1) 
Sow PRRS virus 1 2 
62 MLV - +c 
82 MLV - -
63 ISU-P - -
85 ISU-P - -
75 Neg control - -
95 Neg control - -
C = cell fraction positive 








= virus isolation negative 
+ = virus isolation positive 










Day of Lactation 
6 7 8 9 10 11 
- - - - - -
- ns ns ns ns ns 
- - - - - -
ns ns +c +c - -
ns - - - - -
- - - - - -
Bioassay on VI-
negative samples 
12 13 14 15 16 17 18 Whey Cell fraction fraction 
- - - - - - - + -
ns - ns - - - - + -
- - - - - ns ns - -
- - - - - - - + -
- - - - - - - - -
-
-
- - - - - - -
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Table 2. Viral pathogens shed in mammary secretions 
PATHOGEN SPECIES REFERENCE 
Jembrana virus Bali cattle Soeharsono et al. , 1995 
Feline immunodeficiency virus Cats O'Neil et al., 1996 
Feline leukemia virus Cats Hardy and McClelland, 1975 
Bovine immunodeficiency virus Cattle Nash et al. , 1995 
Bovine leukemia virus Cattle Parfanovic et al. , 1978 
Bovine viral diarrhea virus Cattle Radwan et al. , 1995 
Caprine arthritis-encephalitis virus Goats Adams et al. , 1983 
Junin virus Guinea pigs Sangiorgio and 
Wiessenbacher, 1993 
Cytomegalovirus Humans May, 1988 
Hepatitis B virus Humans May, 1988 
Herpes simplex virus Humans May, 1988 
Human herpes virus 7 Humans Fujisaki et al. , 1998 
Human immunodeficiency virus Humans May, 1988 
Human T-lymphotropic virus type 1 Humans May, 1988 
Rubella virus Humans May, 1988 
V aricella-zooster virus Humans Yoshida et al. , 1992 
Lactate dehydrogenase-elevating virus Mice Broen and Cafruny, 1993 
Mouse mammary tumor virus Mice Henrard and Ross, 1988 
Simian immunodeficiency virus Non-human McClure et al., 1992 
primates 
Maedi-Visna virus Sheep Pepin et al., 1998 
Ovine pleuropneumonia virus Sheep Knowles, 1997 
Foot and mouth disease virus Sheep, cattle, Callens et al. , 1998 Burrows 
and others et al., 1971 
Transmissible gastroenteritis virus Swine Kemeny and Woods, 1977 
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Figure 1. Serum ELISA antibody response in sows experimentally inoculated with modified live PRRSV vaccines. Animals 
were initially inoculated with RespPRRS™ vaccine (Boehringer Ingelheim Vetmedica) and secondly with PrimePac™ PRRS 
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Figure 2. Levels of PRRSV-specific antibodies in whey of mammary secretions from sows inoculated with modified live 
PRRSV vaccines at late gestation as determined by ELISA. Sows 62 and 82 were inoculated with a modified live PRRSV 
vaccine (RespPRRS) at days 86-97 of gestation and with another modified live PRRSV vaccine (PrimePac PRRS) 189 days 
after initial inoculation. Sows 63 and 85 were inoculated with RespPRRS vaccine at days 84-90 of gestation. 
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CONCLUSION 
Mammary secretions play a vital role in the immune function of the neonate. In 
this document the role of mammary secretions in the pig were reviewed. The traditional 
view of mammary secretions primarily as a source of nutrition and antibodies needs to 
be expanded. In addition to antibodies, IgG in colostrum and IgA in milk, there is a 
large cellular component to swine mammary secretions. It has been demonstrated that 
certain populations of these cells cross the intestinal epithelium where they are believed 
to contribute to active immunity in the neonate. Less understood are the non-specific 
antimicrobial components of milk, and their contribution to the immune defenses of the 
neonate. 
While there is great benefit to mammary secretions there is also a risk of disease 
transmission via these secretions. A review of the literature across species suggests that 
viral pathogens are not uncommon in the mammary secretions of infected animals. In 
this document research demonstrating the presence of porcine reproductive and 
respiratory syndrome virus (PRRSV) in mammary secretions of swine was presented. 
PRRSV was demonstrated in both the whey and cellular portions of mammary 
secretions. While virus was demonstrated in the secretions of naive animals challenged 
in late gestation, no virus was detected in previously vaccinated research animals, nor in 
sows in commercial herd which had been previously vaccinated for or exposed to PRRS 
virus. Thus, while transmission of PRRS virus is possible in production settings it seems 
most likely only in nai've animals exposed during gestation. 
